[Hypervitaminosis D due to a dietary supplement]

Area of Science:

• Toxicology
• Nutritional Science
• Public Health

Background:

• Over-the-counter (OTC) dietary supplements are widely available but may pose health risks.
• Regulatory oversight by authorities like the Netherlands Food and Consumer Product Safety Authority (NVWA) may not prevent all adverse events.
• Accurate product labeling is crucial for consumer safety.

Observation:

• A 39-year-old woman presented with severe hypercalcemia, impaired kidney function, headaches, nausea, appetite loss, and weight loss.
• Initial investigations revealed significantly elevated vitamin D levels as the cause of her symptoms.
• The patient reported consuming a concentrated vitamin D supplement obtained from a naturopath.

Findings:

• The consumed vitamin D supplement was found to contain a concentration 78 times higher than indicated on its label.
• This discrepancy highlights a critical issue with product potency and labeling accuracy in the OTC supplement market.
• The severe hypercalcemia and subsequent health problems were directly linked to the excessive vitamin D intake.

Implications:

• Consumers need heightened awareness regarding the potential dangers of OTC dietary supplements, particularly those with unverified concentrations.
• Healthcare providers, including general practitioners (GPs), specialists, and pharmacists, should be vigilant in reporting supplement-related intoxications.
• Increased reporting can facilitate better regulatory control and enforcement against companies with inadequate manufacturing and labeling practices, thereby protecting public health.